...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
AGORACOM NEWS FLASH

Dear Agoracom Family,

I want to thank all of you for your patience with us over the past 48 hours and apologize for what was admittedly a botched launch of our new site.

As you can see, we have reverted back to the previous version of the site while we address multiple forum functionality flaws that inexplicably made their way into the launch.

To this end:

1.We have identified 8 fundamental but easily fixable flaws that will be corrected in the coming week, so that you can continue to use the forums exactly as you've been accustomed to.

2.Additionally we will also be implementing a couple of design improvements to "tighten up" the look and feel of the forums.

Have a great Sunday, especially those of you like me that are celebrating Orthodox Easter ... As well as those of you who are also like me and mourning another Maple Leafs Game 7 exit ... Ugggh!

Sincerely,

George et al

Message: Re: Three news items we're waiting on....

GAC ... the short term financing situation, and regulatory are my two primary items. The Hepa info re renal P3 adds an interesting piece.

But, I am just not very optimistic about the market and pps for RVX as a standalone stock unless/until there is significant news about partnering for the long haul, either a joint partnership with a road map to commercialization (or a buy out). And I think that is dependent on regulatory news (for partnering/valuation) to paint the fuller picture for a partner/buyer. Short term financing (12 months or less) is more for operational, regulatory, and negotiating breathing room toward the real goals. 

Just don't see a reason to believe that RVX will be going it alone for very long, unless BT status is achieved to an extent of HIGH promise, and indicates a shorter and clearer path to approval, that more money can get behind for a while longer? ... but, still motivated toward the real goal of buy out, but at a MUCH higher valuation as we get closer to approval opportunities and further de-risked.  

JMHO

Share
New Message
Please login to post a reply